|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 21, 2018 ) The Market Research on Single-cell Analysis, By Considering useful aspects like; Application, Cell Type — Global Future Forecast till 2022, published by MarketsandMarkets™, the report studies the global Single-cell Analysis market over the forecast period to 2022.
“Consumables segment are expected to witness high growth during forecast period”
Based on product, the single-cell analysis market is segmented into consumables and instruments. Consumables are expected to register the highest CAGR during the forecast period. Consumables are further segmented into beads, microplates, reagents, assay kits, and other consumables, whereas, instruments are further segmented into flow cytometers, NGS systems, PCR instruments, HCS systems, microscopes, cell counters, spectrophotometers, cell microarrays, and other instruments. Players from the market are increasingly focusing on technological advancements and product development to launch efficient cytometry instruments which is driving the growth of the segment.
Request a Sample Copy of “Single-cell Analysis Market” Consist 107 tables and 42 figures spread over 175 pages and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=171955254
“Human cells to dominate the single-cell analysis market”
Based on the type of cells, the single-cell analysis market is segmented into human, animal, and microbial cells. The human cells segment is expected to dominate this market with the largest share in 2017. The large share of this segment can be attributed to the growing application areas of human stem cells and rising incidence of diseases such as cancer.
“NGS to account with the highest growth rate in the single-cell analysis market”
Based on technique, the single-cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). NGS segment is projected to grow at the highest rate during the forecast period.
“North America to dominate the market during forecast period”
In 2017, North America is expected to account for the largest share of the single-cell analysis market. Factors such as increasing collaborations among prominent players, technological advancements and expanding biotechnology and pharmaceutical industries are supporting the growth of the single-cell analysis market in this region. Asian region is expected to register the highest CAGR during the forecast period. The large population in China and India, rising geriatric population, and increasing incidence of chronic diseases are the major factors driving the growth of the Asian market.
The Single-cell Analysis market is fragmented with the presence of emerging players;
The single cell analysis market is highly competitive with the presence of major players. Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General ElectricCompany (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Agilent Technologies (U.S)
Read Full Research Study: https://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.html
MarketsandMarkets
Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
